The promise of novel direct oral anticoagulants

被引：22
|
作者：
Hoffman, Ron [1 ,2 ]
Brenner, Benjamin
机构：
[1] Rambam Hlth Care Campus, Dept Hematol & Bone Marrow Transplantat, In Patient Hematol Unit, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, In Patient Hematol Unit, IL-31096 Haifa, Israel
来源：
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2012年 / 25卷 / 03期
关键词：
thromboembolism; new anticoagulants; direct thrombin inhibitors; factor Xa inhibitors; NONVALVULAR ATRIAL-FIBRILLATION; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; DABIGATRAN ETEXILATE; DOUBLE-BLIND; ANTITHROMBOTIC THERAPY; STROKE PREVENTION; PREDICTING STROKE; KNEE REPLACEMENT;
D O I：
10.1016/j.beha.2012.06.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The standard effective treatment of venous and arterial thromboembolism includes unfractionated and low-molecular weight heparin as well as warfarin, which have major disadvantages. In recent years, new anticoagulants have been developed in an attempt to overcome the known limitations of established treatment and develop improved therapies. This chapter reviews pharmacological properties of the new anticoagulants, the most recent trials assessing their safety and efficacy as well as potential advantages and disadvantages of using these novel drugs in real life. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：351 / 360
页数：10
相关论文
共 50 条
  • [1] Dermatosurgery in the age of novel oral anticoagulants/direct oral anticoagulants
    Loeser, C.
    Nast, A.
    Zeymer, U.
    HAUTARZT, 2019, 70 (11): : 850 - 853
  • [2] New oral anticoagulants show promise
    Hampton, T
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (07): : 743 - 744
  • [3] Direct oral anticoagulants
    Beeton, A.
    SOUTHERN AFRICAN JOURNAL OF ANAESTHESIA AND ANALGESIA, 2023, 29 (05) : S31 - S33
  • [4] Direct oral anticoagulants
    Bouvenot, Gilles
    Bounhoure, Jean-Paul
    Montastruc, Jean-Louis
    Vacheron, Andre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (06): : 1157 - 1195
  • [5] Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants
    Adam, Luise
    Feller, Martin
    Syrogiannouli, Lamprini
    Del-Giovane, Cinzia
    Donze, Jacques
    Baumgartner, Christine
    Segna, Daniel
    Floriani, Carmen
    Roten, Laurent
    Fischer, Urs
    Aeschbacher, Stefanie
    Moschovitis, Giorgio
    Schlapfer, Jurg
    Shah, Dipen
    Amman, Peter
    Kobza, Richard
    Schwenkglenks, Matthias
    Kuehne, Michael
    Bonati, Leo H.
    Beer, Jurg
    Osswald, Stefan
    Conen, David
    Aujesky, Drahomir
    Rodondi, Nicolas
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (04) : 931 - 940
  • [6] Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation
    Femia, Giuseppe
    Fetahovic, Taufik
    Shetty, Pratap
    Lee, Astin
    HEART LUNG AND CIRCULATION, 2018, 27 (07): : 798 - 803
  • [7] Direct Oral Anticoagulants and Women
    Cohen, Hannah
    Arachchillage, Deepa R. J.
    Beyer-Westendorf, Jan
    Middeldorp, Saskia
    Kadir, Rezan A.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (07): : 789 - 797
  • [8] Direct oral anticoagulants (DOACs)
    Vazquez, Sara
    Rondina, Matthew T.
    VASCULAR MEDICINE, 2015, 20 (06) : 575 - 577
  • [9] Direct oral anticoagulants and pregnancy
    Vauzelle, C.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2021, 49 (04): : 301 - 303
  • [10] Direct oral anticoagulants: An update
    Franco Moreno, Ana Isabel
    Martin Diaz, Rosa Maria
    Navarro, Maria Jose Garcia
    MEDICINA CLINICA, 2018, 151 (05): : 198 - 206
12345